# Malaysia Stop Tyrosine Kinase Inhibitor Trial

> **NCT02381379** · PHASE3 · UNKNOWN · sponsor: **Ministry of Health, Malaysia** · enrollment: 118 (estimated)

## Conditions studied

- Leukemia, Chronic Myeloid

## Interventions

- **DRUG:** Peginterferon-α-2a

## Key facts

- **NCT ID:** NCT02381379
- **Lead sponsor:** Ministry of Health, Malaysia
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2018-10
- **Final completion:** 2021-10
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2020-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02381379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02381379, "Malaysia Stop Tyrosine Kinase Inhibitor Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02381379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*